SAREPTA THERAPEUTICS INC Inactive Instrument
MarketScreener Editorial Features Sarepta Therapeutics Inc Nasdaq
Equities
US0023461041
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 03:43pm | Monetary policy is getting even more confusing |  |
| 01:22pm | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
MarketScreener Editorial Features
Search
 | Monetary policy is getting even more confusing | June 26, 2024 at 09:43 am EDT |
 | ANALYST RECOMMENDATIONS : Accenture, Chipotle, Rivian, Walmart, Humana... | June 26, 2024 at 05:22 am EDT |
 | Key week for monetary policy | June 24, 2024 at 09:09 am EDT |
 | ANALYST RECOMMENDATIONS : Accenture, Walgreens Boots Alliance, Ge Vernova, Pepsico, Britvic... | June 24, 2024 at 06:14 am EDT |
 | Tech overload on Wall Street | June 21, 2024 at 09:26 am EDT |
 | ANALYST RECOMMENDATIONS : Home Depot, Apple, Micron Technology, Anglo American, United Utilities... | June 21, 2024 at 05:34 am EDT |
 | Busy week ahead! | January 29, 2024 at 08:44 am EST |
 | Is the market way too optimistic on rates? | April 04, 2023 at 09:25 am EDT |
 | ANALYST RECOMMENDATIONS : Petrofac, Chevron, Comcast, Servicenow, United Bankshares... | April 04, 2023 at 05:55 am EDT |
 | What a relief! | August 10, 2022 at 09:15 am EDT |
 | ANALYST RECOMMENDATIONS : Target, Glencore, Fidelity National Information Services, Moody's, Epam Systems... | August 10, 2022 at 05:32 am EDT |
No results for this search
- Stock Market
- Equities
- SRPT Stock
- Stock
- News Sarepta Therapeutics Inc
- MarketScreener Editorial Features
